This ICR collects information from a low to non-internet user sample regarding their utilization of the components of adequate provision in direct-to-consumer prescription drug broadcast advertising. Additionally, we will examine the impact of statements that could be used to frame risk information in the same context. Using a telephone survey methodology, we plan to conduct one 15-minute pretest with 25 adults followed by a 15-minute main study including 1996 adults.
The latest form for Utilization of Adequate Provision Among Low to Non-Internet Users expires 2021-06-30 and can be found here.
Supporting Statement A
Supporting Statement B
Approved without change
|New collection (Request for a new OMB Control Number)||2018-03-16|
Federal Enterprise Architecture: Health - Consumer Health and Safety